Margaret Lind, PhD
Assistant Professor
Boston University School of Public Health
Epidemiology

PhD, University of Washington School of Public Health
MPH, University of Washington School of Public Health
BS, Western Washington University



Dr. Lind is an Assistant Professor of Infectious Disease Epidemiology at the Boston University School of Public Health. Her research leverages large retrospective data sources and causal inference methods to better understand and reduce the burden of infectious diseases.

Her work integrates statistical and mathematical modeling to evaluate vaccination strategies, non-pharmaceutical interventions, and treatment policies, including the effects of infection and infection treatment on longer-term health outcomes beyond the acute disease period. This work aims to inform public health policy and clinical guidance by improving infectious disease prevention strategies and risk prediction.

She holds both an MPH and PhD in Epidemiology from the University of Washington and completed her postdoctoral training at Yale University.


Understanding willingness and obstacles to implementing HIV pre-exposure prophylaxis (PrEP) and hepatitis C virus (HCV) treatment in prenatal and postpartum care
01/01/2026 - 12/31/2026 (Subcontract PI)
The Miriam Hospital NIH NIAID
5P30AI042853-27

Identifying and evaluating prevention strategies for COVID-19 in correctional facilities
09/04/2024 - 08/31/2026 (PI)
NIH/National Institute of Allergy & Infectious Diseases
5R00AI177945-04



Title

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Kim C, Kennedy BS, Lansing M, Richeson RP, Hitchings M, Ko AI, Lind ML. Mass SARS-CoV-2 testing in US correctional facilities during the pandemic: a longitudinal analysis. BMJ Public Health. 2025; 3(2):e003641. PMID: 41431610; DOI: 10.1136/bmjph-2025-003641;
     
  2. Lind ML, Goldmann E, Lalonde GS. Trends in influenza vaccine disparities in the U.S. following the introduction of COVID-19: Insights from the national health interview survey. Prev Med Rep. 2025 Dec; 60:103288.View Related Profiles. PMID: 41216138; DOI: 10.1016/j.pmedr.2025.103288;
     
  3. Serina PT, Stavrand A, Lind ML, Gettel CJ, Southerland LT, Goldberg EM. Nursing Home to Emergency Care Transition Form Has Limited Uptake But Improves Documentation. J Am Med Dir Assoc. 2024 Aug; 25(8):105056. PMID: 38843872; DOI: 10.1016/j.jamda.2024.105056;
     
  4. Lazar Neto F, Hitchings MDT, Amin AB, de França GVA, Lind ML, Scaramuzzini Torres MS, Tsuha DH, de Oliveira RD, Cummings DAT, Dean NE, Andrews JR, Ko AI, Croda J, Ranzani OT. Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort study. Lancet Reg Health Am. 2024 Jun; 34:100755. PMID: 38737773; DOI: 10.1016/j.lana.2024.100755;
     
  5. Dorión M, Ticona JPA, Fofona MO, Lind ML, Nery N, Victoriano R, do Aragão Filho AS, Reis MG, Costa F, Ko AI. Social determinants of adult COVID-19 vaccine acceptance and uptake in a Brazilian urban informal community: a longitudinal time-to-event study. medRxiv. 2023 Nov 28. PMID: 38076979; DOI: 10.1101/2023.11.28.23298927;
     
  6. Lind ML, Dorion M, Houde AJ, Lansing M, Lapidus S, Thomas R, Yildirim I, Omer SB, Schulz WL, Andrews JR, Hitchings MDT, Kennedy BS, Richeson RP, Cummings DAT, Ko AI. Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population. Nat Commun. 2023 Aug 19; 14(1):5055. PMID: 37598213; DOI: 10.1038/s41467-023-40750-8;
     
  7. Lind ML, Kennedy BS, Nieto MD, Houde AJ, Sosensky P, Borg R, Cummings DAT, Ko AI, Richeson RP. Covid-19 vaccine acceptance among individuals incarcerated in Connecticut state jails. Health Justice. 2023 Mar 13; 11(1):16. PMID: 36913159; DOI: 10.1186/s40352-023-00216-x;
     
  8. Lind ML, Copin R, McCarthy S, Coppi A, Warner F, Ferguson D, Duckwall C, Borg R, Muenker MC, Overton J, Hamon S, Zhou A, Cummings DAT, Ko AI, Hamilton JD, Schulz WL, Hitchings MDT. Use of Whole-Genome Sequencing to Estimate the Contribution of Immune Evasion and Waning Immunity on Decreasing COVID-19 Vaccine Effectiveness. J Infect Dis. 2023 Mar 01; 227(5):663-674. PMID: 36408616; DOI: 10.1093/infdis/jiac453;
     
  9. Lind ML, Schultes OL, Robertson AJ, Houde AJ, Cummings DAT, Ko AI, Kennedy BS, Richeson RP. Testing Frequency Matters: An Evaluation of the Diagnostic Performance of a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Rapid Antigen Test in US Correctional Facilities. Clin Infect Dis. 2023 Feb 08; 76(3):e327-e335. PMID: 35686341; DOI: 10.1093/cid/ciac450;
     
  10. Lind ML, Robertson AJ, Silva J, Warner F, Coppi AC, Price N, Duckwall C, Sosensky P, Di Giuseppe EC, Borg R, Fofana MO, Ranzani OT, Dean NE, Andrews JR, Croda J, Iwasaki A, Cummings DAT, Ko AI, Hitchings MDT, Schulz WL. Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case-control analysis. PLoS Med. 2022 Dec; 19(12):e1004136. PMID: 36454733; DOI: 10.1371/journal.pmed.1004136;
     
Showing 10 of 33 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 33 publications over 13 distinct years, with a maximum of 5 publications in 2021 and 2022 and 2023

YearPublications
20131
20141
20153
20163
20171
20181
20191
20203
20215
20225
20235
20242
20252
Contact for Mentoring:

715 Albany St
Boston MA 02118
Google Map


Lind's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department